Minji Kim
Directeur/Membre du Conseil chez SK BIOPHARMACEUTICALS CO., LTD.
Profil
Dr. Minji Kim is a Chief Business Officer at Mineralys Therapeutics, Inc. and an Independent Director at SK Biopharmaceuticals Co., Ltd.
She is on the Board of Directors at SK Biopharmaceuticals Co., Ltd.
Dr. Kim was previously employed as a Vice President-Corporate & Business Development by Curis, Inc., a General Manager-Affamed Digital by Affamed Therapeutics (Us), Inc., an Associate-Global Business Development & Licensing by Hoffmann-La Roche, Inc., and a Head-Business Development & Alliance Management by Jounce Therapeutics, Inc. She received her MBA from Yale University and a doctorate degree from Seoul National University.
Postes actifs de Minji Kim
| Sociétés | Poste | Début |
|---|---|---|
| MINERALYS THERAPEUTICS, INC. | Corporate Officer/Principal | 04/01/2024 |
| SK BIOPHARMACEUTICALS CO., LTD. | Directeur/Membre du Conseil | - |
Anciens postes connus de Minji Kim
| Sociétés | Poste | Fin |
|---|---|---|
| JOUNCE THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Corporate Officer/Principal | - |
Affamed Therapeutics (Us), Inc.
 Affamed Therapeutics (Us), Inc. Pharmaceuticals: MajorHealth Technology Part of AffaMed Therapeutics, Affamed Therapeutics (US), Inc. is a clinical stage biopharmaceutical company based in New York, NY. The company focuses on developing and commercializing pharmaceutical, digital, and surgical products to address critical unmet medical needs in ophthalmological, neurological, and psychiatric disorders for patients worldwide. The CEO of the company is Dayao Zhao. | Corporate Officer/Principal | - |
| CURIS, INC. | Corporate Officer/Principal | - |
Formation de Minji Kim
| Seoul National University | Doctorate Degree |
| Yale University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| CURIS, INC. | Health Technology |
| MINERALYS THERAPEUTICS, INC. | Health Technology |
| SK BIOPHARMACEUTICALS CO., LTD. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
Affamed Therapeutics (Us), Inc.
Affamed Therapeutics (Us), Inc. Pharmaceuticals: MajorHealth Technology Part of AffaMed Therapeutics, Affamed Therapeutics (US), Inc. is a clinical stage biopharmaceutical company based in New York, NY. The company focuses on developing and commercializing pharmaceutical, digital, and surgical products to address critical unmet medical needs in ophthalmological, neurological, and psychiatric disorders for patients worldwide. The CEO of the company is Dayao Zhao. | Health Technology |
Jounce Therapeutics, Inc.
 Jounce Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Jounce Therapeutics, Inc. is a clinical stage immunotherapy company, which engages in developing treatments for cancer. It also provides novel cancer immunotherapies to attack tumors. The company was founded by Louis M. Weiner, Drew M. Pardoll, Thomas F. Gajewski, James P. Allison, Robert Schreiber, and Padmanee Sharma in 2013 and is headquartered in Cambridge, MA. | Commercial Services |
